Latest news
Energenesis and Taiwan Tanabe Sign Development Agreement for Diabetic Foot Ulcer Drug ENERGI-F703DFU - geneonline.comgeneonline.com · Mon, 10 Aug 2026 10:29:45 GMTEnergenesis and Taiwan Tanabe to develop ENERGI-F703DFU for DFUs - Pharmaceutical TechnologyPharmaceutical Technology · Mon, 10 Aug 2026 08:48:19 GMTEnergenesis Biomedical partners with Taiwan Tanabe Seiyaku to develop topical drug for diabetic foot ulcers - BioSpectrum AsiaBioSpectrum Asia · Fri, 07 Aug 2026 19:18:45 GMTEnergenesis Biomedical and Taiwan Tanabe Seiyaku Enter Joint Development Agreement for ENERGI-F703DFU - PR NewswirePR Newswire · Thu, 06 Aug 2026 23:00:00 GMT